| Bay Regional & Intl Inst. Of Neurology, Inc | |
|
2508 W. Saint Isabel Street Suite A Tampa FL 33607-6380 | |
| (813) 876-3783 | |
| (813) 876-2525 |
| Full Name | Bay Regional & Intl Inst. Of Neurology, Inc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 2508 W. Saint Isabel Street, Tampa, Florida |
| Authorized Official Name and Position | Radhakrishna K. Rao (PRESIDENT) |
| Authorized Official Contact | 8138763783 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Bay Regional & Intl Inst. Of Neurology, Inc 2508 W. Saint Isabel Street Suite A Tampa FL 33607-6380 Ph: (813) 876-3783 | Bay Regional & Intl Inst. Of Neurology, Inc 2508 W. Saint Isabel Street Suite A Tampa FL 33607-6380 Ph: (813) 876-3783 |
| NPI Number | 1215999446 |
|---|---|
| Provider Enumeration Date | 04/04/2006 |
| Last Update Date | 10/07/2008 |
| Medicare PECOS PAC ID | 1052455219 |
|---|---|
| Medicare Enrollment ID | O20100225000778 |
News Archive
Talecris Biotherapeutics, Inc., today announced results of a new survey showing that Gamunex® (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) is the preferred immune globulin intravenous (IGIV) among neurologists who indicated a brand preference. In the survey, conducted online by Harris Interactive® on behalf of Talecris, neurologists selected Gamunex over four times more often than all other available liquid IGIV therapies, with a statistically significant margin (p<0.05).
Researchers from New York University found that certain bacteria from the mouth may be related to preterm delivery and low birthweight according to a study in the Journal of Periodontology (JOP).
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced positive preliminary results of a Phase IIa study in inflammatory bowel disease (IBD) with its lead autoimmune compound vidofludimus, an oral inhibitor of interleukin-17 (IL-17) release.
Baxa Corporation today announced its rank of 3,494 on the Inc. 5000 list of the fastest-growing private businesses in the United States. This year marks the fourth consecutive year that Baxa, a leading provider of medical devices and systems that automate pharmacy operations, has been listed on the prestigious Inc. 5000 list.
Rare cancers inherently make it difficult to collect data, build clinical expertise and treat affected patients - challenges which are best addressed through collaboration in international networks.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215999446 | NPI | - | NPPES |
| 375370100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0402X | Psychiatry & Neurology - Neurology With Special Qualifications In Child Neurology | (* (Not Available)) | Primary |
| Provider Name | Radhakrisha K Rao |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1326264177 PECOS PAC ID: 2264576420 Enrollment ID: I20100225000765 |
News Archive
Talecris Biotherapeutics, Inc., today announced results of a new survey showing that Gamunex® (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) is the preferred immune globulin intravenous (IGIV) among neurologists who indicated a brand preference. In the survey, conducted online by Harris Interactive® on behalf of Talecris, neurologists selected Gamunex over four times more often than all other available liquid IGIV therapies, with a statistically significant margin (p<0.05).
Researchers from New York University found that certain bacteria from the mouth may be related to preterm delivery and low birthweight according to a study in the Journal of Periodontology (JOP).
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced positive preliminary results of a Phase IIa study in inflammatory bowel disease (IBD) with its lead autoimmune compound vidofludimus, an oral inhibitor of interleukin-17 (IL-17) release.
Baxa Corporation today announced its rank of 3,494 on the Inc. 5000 list of the fastest-growing private businesses in the United States. This year marks the fourth consecutive year that Baxa, a leading provider of medical devices and systems that automate pharmacy operations, has been listed on the prestigious Inc. 5000 list.
Rare cancers inherently make it difficult to collect data, build clinical expertise and treat affected patients - challenges which are best addressed through collaboration in international networks.
› Verified 5 days ago
News Archive
Talecris Biotherapeutics, Inc., today announced results of a new survey showing that Gamunex® (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) is the preferred immune globulin intravenous (IGIV) among neurologists who indicated a brand preference. In the survey, conducted online by Harris Interactive® on behalf of Talecris, neurologists selected Gamunex over four times more often than all other available liquid IGIV therapies, with a statistically significant margin (p<0.05).
Researchers from New York University found that certain bacteria from the mouth may be related to preterm delivery and low birthweight according to a study in the Journal of Periodontology (JOP).
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced positive preliminary results of a Phase IIa study in inflammatory bowel disease (IBD) with its lead autoimmune compound vidofludimus, an oral inhibitor of interleukin-17 (IL-17) release.
Baxa Corporation today announced its rank of 3,494 on the Inc. 5000 list of the fastest-growing private businesses in the United States. This year marks the fourth consecutive year that Baxa, a leading provider of medical devices and systems that automate pharmacy operations, has been listed on the prestigious Inc. 5000 list.
Rare cancers inherently make it difficult to collect data, build clinical expertise and treat affected patients - challenges which are best addressed through collaboration in international networks.
› Verified 5 days ago
Avalon Behavior Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1190 E Washington St, Ph29, Tampa, FL 33602 Phone: 510-313-8290 | |
Varghese Kodiyan Pa Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 602 Shellcracker Ct, Tampa, FL 33613 Phone: 813-245-7326 | |
Tampa Life Counseling, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 13035 W. Linebaugh Ave #101 Ste G, Tampa, FL 33626 Phone: 813-906-8852 | |
Embracing Changes Center For Wellness Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4830 W Kennedy Blvd Ste 630, Tampa, FL 33609 Phone: 813-486-4920 Fax: 813-428-5756 | |
Vip Senior Wellness Services Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 10115 Vista Pointe Dr, Tampa, FL 33635 Phone: 718-942-6595 | |
Crudup Psychological Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 10001 Cross Creek Blvd, Tampa, FL 33647 Phone: 386-243-9220 | |
Grow, Empower, Transform Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13542 N Florida Ave Ste 210, Tampa, FL 33613 Phone: 813-563-8227 |